On The Road Again

Located in Fayetteville, NC, On The Road Again operates in NC's broader addiction-treatment market. The facility's programming is outpatient (IOP), not residential. What this page tries to do is frame the specific questions worth asking, which are rarely the ones that get asked first.

Care levels at On The Road Again

What On The Road Again offers: On The Road Again is an outpatient-focused program (IOP) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. What matters is whether that matches the specific clinical picture, which only a proper assessment can tell. Most mismatches happen when the assessment is skipped or done inside the facility with a commercial interest in admission.

Insurance and payment

On The Road Again operates primarily on commercial insurance. The implication for patients: higher typical cost-share, potentially more intensive programming, and the full burden of MHPAEA parity-rule dynamics — including appeal rights when the plan denies. Most post-treatment billing disputes trace back to a specific moment when an admissions counselor said one thing and the benefits department later documented something else. Avoid the moment by getting the written VOB before admission, not after.

Specialty programming

The facility's documented specialty programming includes: Young adults, Adult women, Adult men. A facility's specialty designation is a starting filter, not an endorsement. The operational questions (who leads it, how many hours per week, what credentials) are where the actual answer lives.

Before you call

Questions that matter before admitting to On The Road Again: ASAM level of care (not the facility's category, the clinical level); written VOB; MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether On The Road Again offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. The ones who answer those quickly are usually the ones worth considering. The ones who dodge are almost always worth skipping.